Research Students
One of the most rewarding part of my work is to support, train and advise enthusiastic and bright students on...
My Current Research
My research focuses on the limitation of currently available pharmacological treatments for Alzheimer’s disease and Schizophrenia. To find new treatment avenues I study...
Paper: Metabotropic glutamate receptor 5 and its trafficking molecules, Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia
Our manuscript on altered mGluR5 expression and signaling in individuals with schizophrenia just got published in Schizophrenia Research: Metabotropic glutamate receptor...
Paper: Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation
Our manuscript on altered mGluR5 expression and signaling in individuals with schizophrenia just got published in Acta Neuropathologica: Alterations of mGluR5...
Paper: Neuregulin 1 prevents phencyclidine-induced behavioral impairments and disruptions to GABAergic signaling in mice
We published the first evidence for an antipsychotic treatment potential of neuregulin 1. Acute neuregulin 1 treatment reduced acute episode-like...
Presentations
Public Talks Neuregulin-1 application reduces Phencyclidine-induced neurotransmitter level alterations in freely moving adult mice. Biennial Australasian Schizophrenia Conference 2013, Melbourne,...
Paper: Negativity towards negative results: a discussion of the disconnect between scientific worth and scientific culture
Our editorial on negativity towards negative results: a discussion of publication bias. Natalie Matosin, Elisabeth Frank, Martin Engel, Jeremy Lum...